Reisfeld; Ralph A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Reisfeld; Ralph A..The latest application filed is for "nanoparticle-based tumor-targeted drug delivery".

Company Profile

1.20.18

Reisfeld; Ralph A. - La Jolla CA
Reisfeld; Ralph A - La Jolla CA
Reisfeld; Ralph A. - LaJolla CA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Nanoparticle-based tumor-targeted drug delivery Grant 10,335,420 - Reisfeld , et al.	2019-07-02
Nanoparticle-based Tumor-targeted Drug Delivery App 20170224838 - REISFELD; Ralph A. ; et al.	2017-08-10
DNA vaccines against tumor growth and methods of use thereof Grant 9,655,815 - Xiang , et al. May 23, 2	2017-05-23
Nanoparticle-based tumor-targeted drug delivery Grant 9,629,922 - Reisfeld , et al. April 25, 2	2017-04-25
Nanoparticle-based tumor-targeted drug delivery Grant 9,616,137 - Reisfeld , et al. April 11, 2	2017-04-11
Dna Composition For Eliciting An Immune Response Against Tumor-associated Macrophages App 20150175996 - Reisfeld; Ralph A. ; et al.	2015-06-25
Dna Vaccines Against Tumor Growth And Methods Of Use Thereof App 20140322249 - Xiang; Rong ; et al.	2014-10-30
DNA vaccines against tumor growth and methods of use thereof Grant 8,716,254 - Xiang , et al. May 6, 2	2014-05-06
Nanoparticle-based Tumor-targeted Drug Delivery App 20130330399 - Reisfeld; Ralph A. ; et al.	2013-12-12
DNA composition encoding an immunogenic VEGF receptor peptide and methods of use thereof Grant 8,241,637 - Reisfeld , et al. August 14, 2	2012-08-14
Nanoparticle-based Tumor-targeted Drug Delivery App 20120058177 - Reisfeld; Ralph A. ; et al.	2012-03-08
Dna Composition Encoding An Immunogenic Vegf Receptor Peptide And Methods Of Use Thereof App 20120039931 - REISFELD; Ralph A. ; et al.	2012-02-16
DNA vaccines against tumor growth and methods of use thereof Grant 8,053,421 - Luo , et al. November 8, 2	2011-11-08
DNA composition encoding an immunogenic VEGF receptor peptide and methods of use thereof Grant 8,048,428 - Reisfeld , et al. November 1, 2	2011-11-01
Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies Grant 7,833,976 - Lode , et al. November 16, 2	2010-11-16
DNA vaccines against tumor growth and methods of use thereof App 20100136058 - Luo; Yunping ; et al.	2010-06-03
Dna Composition For Eliciting An Immune Response Against Tumor-associated Macrophages App 20090275642 - Reisfeld; Ralph A. ; et al.	2009-11-05
DNA composition against tumor stromal antigen FAP and methods of use thereof App 20090253778 - Reisfeld; Ralph A. ; et al.	2009-10-08
DNA vaccines against tumor growth and methods of use therof Grant 7,569,552 - Luo , et al. August 4, 2	2009-08-04
Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies App 20090060864 - Lode; Holger N. ; et al.	2009-03-05
Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies Grant 7,365,054 - Lode , et al. April 29, 2	2008-04-29
DNA vaccines encoding CEA and a CD40 ligand and methods of use thereof Grant 7,279,464 - Xiang , et al. October 9, 2	2007-10-09
Dna vaccines against tumor growth and methods of use thereof App 20070110717 - Luo; Yunping ; et al.	2007-05-17
DNA composition encoding an immunogenic VEGF receptor peptide and methods of use thereof App 20070059323 - Reisfeld; Ralph A. ; et al.	2007-03-15
Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies App 20070036751 - Lode; Holger N. ; et al.	2007-02-15
Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies Grant 7,115,261 - Lode , et al. October 3, 2	2006-10-03
DNA vaccine against proliferating endothelial cells and methods of use thereof Grant 7,094,410 - Reisfeld , et al. August 22, 2	2006-08-22
DNA vaccines encoding CEA and a CD40 ligand and methods of use thereof App 20050287123 - Xiang, Rong ; et al.	2005-12-29
DNA vaccines encoding CEA and a CD40 ligand and methods of use thereof Grant 6,923,958 - Xiang , et al. August 2, 2	2005-08-02
DNA vaccines against tumor growth and methods of use thereof App 20040192631 - Xiang, Rong ; et al.	2004-09-30
DNA vaccine against proliferating endothelial cells and methods of use thereof App 20030185802 - Reisfeld, Ralph A. ; et al.	2003-10-02
DNA vaccines encoding CEA and a CD40 ligand and methods of use thereof App 20030176377 - Xiang, Rong ; et al.	2003-09-18
EX vivo effector cell activation for target cell killing Grant 4,844,893 - Honsik , et al. July 4, 1	1989-07-04
Monoclonal antibody directed to human ganglioside GD.sub.2 Grant 4,675,287 - Reisfeld , et al. June 23, 1	1987-06-23

Company Registrations

NCAGE Code	4EFX9	REISFELD RALPH A
CAGE Code	4EFX9	REISFELD, RALPH A

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.